Because of the poor solubility of the commercially available bisacylphosphine oxides in dental acidic aqueous primer formulations, bis(3-{[2-(allyloxy)ethoxy]methyl}-2,4,6-trimethylbenzoyl)(phenyl)phosphine oxide (WBAPO) was synthesized starting from 3-(chloromethyl)-2,4,6-trimethylbenzoic acid by the dichlorophosphine route. The substituent was introduced by etherification with 2-(allyloxy)ethanol. In the second step, 3-{[2-(allyloxy)ethoxy]methyl}-2,4,6-trimethylbenzoic acid was chlorinated. The formed acid chloride showed an unexpected low thermal stability. Its thermal rearrangement at 180 ° C resulted in a fast formation of 3-(chloromethyl)-2,4,6-trimethylbenzoic acid 2-(allyloxy)ethyl ester. In the third step, the acid chloride was reacted with phenylphosphine dilithium with the formation of bis(3-{[2-(allyloxy)ethoxy]methyl}-2,4,6-trimethylbenzoyl)(phenyl)phosphine, which was oxidized to WBAPO. The structure of WBAPO was confirmed by ¹H NMR, ¹³C NMR, ³¹P NMR, and IR spectroscopy, as well as elemental analysis. WBAPO, a yellow liquid, possesses improved solubility in polar solvents and shows UV-vis absorption, and a high photoreactivity comparable with the commercially available bisacylphosphine oxides. A sufficient storage stability was found in dental acidic aqueous primer formulations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874277PMC
http://dx.doi.org/10.3762/bjoc.6.26DOI Listing

Publication Analysis

Top Keywords

bis3-{[2-allyloxyethoxy]methyl}-246-trimethylbenzoylphenylphosphine oxide
8
commercially bisacylphosphine
8
bisacylphosphine oxides
8
dental acidic
8
acidic aqueous
8
aqueous primer
8
primer formulations
8
3-chloromethyl-246-trimethylbenzoic acid
8
acid chloride
8
acid
5

Similar Publications

Bis(pyrazol-1-yl)acetic acid (HC(pz)COOH) and bis(3,5-dimethyl-pyrazol-1-yl)acetic acid (HC(pz)COOH) were converted into the methyl ester derivatives (L) and (L), respectively, and were used for the preparation of silver(I) complexes -. The Ag(I) complexes were prepared by the reaction of AgNO and 1,3,5-triaza-7-phosphaadamantane (PTA) or triphenylphosphine (PPh) with L and L in methanol solution. All Ag(I) complexes showed a significant in vitro antitumor activity, proving to be more effective than the reference drug cisplatin in the in-house human cancer cell line panel containing examples of different solid tumors.

View Article and Find Full Text PDF

Oxoiron(IV) is a common catalytic byproduct observed in the oxidation of alkenes by the combination of HO and nonheme iron catalysts including complex , FePDP* (where PDP* = bis(3,5-dimethyl-4-methoxypyridyl-2-methyl)-(,)-2,2'-bipyrrolidine). The oxoiron(IV) species have been proposed to arise by O-O homolysis of the peroxyiron(III) or acylperoxyiron(III) intermediates formed during the presumed Fe-Fe catalytic cycle and have generally been regarded as off-pathway. We generated complex (λ = 730 nm, ε = 350 M cm) directly from and an oxygen atom donor IBX (isopropyl 2-iodoxybenzoate) in acetonitrile in the temperature range from -35 to +25 °C under stopped-flow conditions.

View Article and Find Full Text PDF

Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.

J Inorg Biochem

March 2018

Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-783 71 Olomouc, Czech Republic. Electronic address:

The Cu(II) complexes [Cu(bpdmpz)Cl]ClO (1), [Cu(bdmpzp)Cl]ClO (2-ClO), [Cu(bdmpzp)Cl]PF (2-PF) and [Cu(tdmpza)Cl]ClO (3), bpdmpzp=[bis[((2-pyridylmethyl)-di(3,5-dimethyl-1H-pyrazolyl)methyl)]amine, bdmpzp=[bis((di(3,5-dimethyl-1H-pyrazolyl)methyl)-(2-pyridylmethyl)]amine and tdmpza=tris[di(3,5-dimethyl-1H-pyrazolyl)-methyl)]amine were synthesized and characterized by elemental analysis, magnetic and conductivity measurements, electrospray-ionization mass spectrometry, infrared and electronic spectroscopy, and X-ray crystallography. The magnetic properties of the complexes, measured at variable temperature, revealed weak antiferromagnetic intermolecular interactions. The cytotoxicity of the complexes 1, 2-ClO, 3, and 4 ([Cu(bedmpzp)Cl]PF, where bedmpzp=[bis(3,5-dimethyl-1H-pyrazol-1-yl-1-ethyl)-(2-pyridylmethyl)]amine), was investigated against four human cancer cell lines: A2780 (ovarian), A2780R (cisplatin-resistant variant), HOS (aggressive bone tumors), CaCo2 (epithelial colorectal adenocarcinoma) and on healthy human hepatocytes.

View Article and Find Full Text PDF

New nitroimidazole and glucosamine conjugated heteroscorpionate ligands, namely 2,2-bis(3,5-dimethyl-1H-pyrazol-1-yl)-N-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl)acetamide (L(MN)) and 1,3,4,6-tetra-O-acetyl-2-{[bis(3,5-dimethyl-1H-pyrazol-1-yl)acetyl]amino}-2-deoxy-β-D-glucopyranose (L(DAC)), respectively, were synthesized by direct coupling of preformed side chain acid and amine components. The related copper(II) complexes {[(L(MN))(2)Cu]Cl(2)}, and {[(L(DAC))(2)Cu]Cl(2)} have been prepared from the reaction of CuCl(2)*2H(2)O with L(MN) or L(DAC) ligand in methanol solution. Single crystal structural characterization was undertaken for the L(MN) ligand.

View Article and Find Full Text PDF

Because of the poor solubility of the commercially available bisacylphosphine oxides in dental acidic aqueous primer formulations, bis(3-{[2-(allyloxy)ethoxy]methyl}-2,4,6-trimethylbenzoyl)(phenyl)phosphine oxide (WBAPO) was synthesized starting from 3-(chloromethyl)-2,4,6-trimethylbenzoic acid by the dichlorophosphine route. The substituent was introduced by etherification with 2-(allyloxy)ethanol. In the second step, 3-{[2-(allyloxy)ethoxy]methyl}-2,4,6-trimethylbenzoic acid was chlorinated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!